Navigation Links
AMPK and inflammatory mediators are involved in postoperative cognitive dysfunction
Date:5/6/2014

Postoperative cognitive dysfunction is associated with neuronal apoptosis, which may result from post-surgery inflammation, the phosphorylation of tau protein and the accumulation of amyloid in aged people. 5′adenosine monophosphate-activated protein kinase (AMPK) can be involved in anti-inflammation, neuronal repair and anti-inflammation of the body through different downstream proteins and pathways. In addition, the activation of AMPK regulates tau protein phosphorylation and reduces amyloidogenesis in neurons. Yanlin Bi and co-workers from the Affiliated Qianfoshan Hospital of Shandong University in China found that inflammatory cytokines and AMPK changed remarkably in the hippocampus of postoperative cognitive dysfunction rats. Therefore, the involvement of AMPK and inflammatory factors in postoperative cognitive dysfunction is considered to be an accommodation to postoperative cognitive dysfunction. The relevant study has been published in the Neural Regeneration Research (Vol. 9, No. 5, 2014).


'/>"/>

Contact: Meng Zhao
eic@nrren.org
86-138-049-98773
Neural Regeneration Research
Source:Eurekalert  

Page: 1

Related medicine news :

1. Researchers develop a new cell and animal model of inflammatory breast cancer
2. Not taking gastroprotective drugs prescribed with anti-inflammatory medicines
3. New Treatments Emerging from Immune and Inflammatory Disease R&D Pipelines
4. New anti-inflammatory drugs pinch off reactive oxygen species at the source
5. Discovery improves understanding of early onset inflammatory disease
6. Decreasing cancer risk associated with inflammatory bowel disease
7. Inflammatory pathway spurs cancer stem cells to resist HER2-targeted breast cancer treatment
8. UNC team describes novel inflammatory protein function
9. NIH launches trial to evaluate anti-inflammatory treatment for preventing heart attacks, strokes, and cardiovascular deaths
10. Multi-functional anti-inflammatory/anti-allergic developed by Hebrew University researcher
11. New light on the genetic basis of inflammatory diseases
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
AMPK and inflammatory mediators are involved in postoperative cognitive dysfunction
(Date:6/25/2016)... ... ... of Bruton Memorial Library on June 21 due to a possible lice infestation, as reported ... head lice: the parasite’s ability to live away from a human host, and to infest ... in the event that lice have simply gotten out of control. , As lice are ...
(Date:6/25/2016)... ... 25, 2016 , ... First Choice Emergency Room , the largest network ... the Medical Director of its new Mesquite-Samuell Farm facility. , “We are pleased ... location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, ... the latter, setting the bar too high can result in disappointment, perhaps even self-loathing. ... toward their goal. , Research from PsychTests.com reveals that behind the ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Those who have ... these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as ... Michigan, has released tools for healthy coping following a traumatic event. , Trauma sufferers ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Dialysis Devices Global Market - Forecast to 2022" report ... is the treatment method for the patients with kidney failure, ... and excess fluid from the patient,s blood and thus the ... sodium, potassium and chloride in balance. Increasing ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it ... (procalcitonin) assay as a dedicated testing solution for people ... Roche is the first IVD company in the U.S ... assessment and management. PCT is a sepsis-specific ... blood can aid clinicians in assessing the risk of ...
(Date:6/23/2016)... Bracket , a leading clinical trial technology ... outcomes platform, Bracket eCOA (SM) 6.0, at the 52 ... 30, 2016 in Philadelphia , Pennsylvania.  A ... product of its kind to fully integrate with RTSM, will ... 6.0 is a flexible platform for electronic clinical outcomes assessments ...
Breaking Medicine Technology: